Reduction of daunorubicin lethality and myocardial cellular alterations by pretreatment with ICRF-187 in Syrian golden hamsters.
D000818:Animals; D001835:Body Weight; D056486:Chemical and Drug Induced Liver Injury; D006224:Cricetinae; D003630:Daunorubicin / Q000037:antagonists & inhibitors* / Q000633:toxicity; D006331:Heart Diseases / Q000139:chemically induced / Q000517:prevention & control*; D008099:Liver / Q000187:drug effects / Q000473:pathology; D008107:Liver Diseases / Q000517:prevention & control; D008297:Male; D008647:Mesocricetus; D009206:Myocardium / Q000473:pathology; D010879:Piperazines / Q000494:pharmacology*; D051381:Rats; D011929:Razoxane / Q000494:pharmacology*; D013237:Stereoisomerism; D013997:Time Factors
D010879:Piperazines; D011929:Razoxane; D003630:Daunorubicin